Overview

Short Term Safety and Efficacy of Lubiprostone in Adults With Cystic Fibrosis

Status:
Completed
Trial end date:
2009-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the short term safety and effectiveness of lubiprostone when used for constipation in adults with cystic fibrosis.
Phase:
N/A
Details
Lead Sponsor:
University of Arkansas
Collaborator:
Takeda Pharmaceuticals North America, Inc.
Treatments:
Lubiprostone